Large Market Deal of the Year: EQT and Aldevron
EQT sold Aldevron for $9.6bn just 22 months after buying the maker of mRNA vaccine components for $3.4bn.
1 April 2022•4 mins read
EQT sold Aldevron for $9.6bn just 22 months after buying the maker of mRNA vaccine components for $3.4bn.
KKR’s Alisa Wood: PE isn’t worth it if you can’t access top GPs
21 October 2026 · 3 mins read
DOWNLOAD: Private equity fundraising stays on growth path despite Q3 dip
19 October 2026 · 2 mins read
Fund performance: Is the worst over or yet to come?
14 October 2026 · 7 mins read
Download the October 2026 issue of Buyouts
1 October 2026 · 1 min read
Going hybrid: A new solution for a complex market
1 October 2026 · 10 mins read
Medtech moves into private equity’s sweet spot
1 October 2026 · 7 mins read
Deal watch: Specialty pharmacy
1 October 2026 · 2 mins read
